On 05 May 2021, Novo Nordisk A/S will announce the Q1 2021 results before the opening of the NASDAQ Copenhagen stock exchange.
A conference call will follow the announcement at:
13.00-14.00 (CET), 12.00-13.00 (BST), 07.00-08.00 (EST)
Please access the conference call using one of the following numbers
and the confirmation code:
Denmark: +45 3544 5577
UK and international: +44 333 300 0804
USA: +1 631 913 1422
Confirmation code: 39488831#
If you have any questions, you are welcome to contact Novo Nordisk
Investor Relations:
Daniel Muusmann Bohsen: +45 3075 2175
Valdemar Borum Svarrer: +45 3079 0301
Ann Søndermølle Rendbæk: +45 3075 2253
Mark Joseph Root : +45 3079 4211
Slides for the conference call will be available here approximately one hour before the event.
- Annual General Meeting 2021 (25 March 2021)
- Dividend payment for B shares (30 March 2021)
- Silent period (1 April - 5 May 2021)
- Dividend payment for ADRs (9 April 2021)
- Q1 2021 financial results release (5 May 2021)
- Silent period (1 July - 5 August 2021)
- Q2 2021 financial results release (5 August 2021)
- Interim dividend payment for B shares (18 August 2021)
- Interim dividend payment for ADRs (25 August 2021)
- Silent period (1 October - 3 November 2021)
- Q3 2021 financial results release (3 November 2021)
- Annual report 2020 (UK)
-
Company
announcement
- Novo Nordisk CEO reflects on the full year results (video)
- Investor presentation
-
Conference call webcast (03 February 2021,
13:00 CET)
- Conference call audio link (03 February 2021, 13:00 CET)
- London webcast (05 February 2021, 12:00 CET)
- London earnings presentation audio link (05 February 2021, 12:00 CET)
- Financial workbook
- Company Announcement
- Investor presentation
- Conference call webcast (30 Oct 2020, 13:00 CET)
- Conference call audio link (30 Oct 2020, 13:00 CET)
- London webcast (2 Nov 2020, 13:00 CET)
- London earnings presentation audio link (2 Nov 2020, 13:00 CET)
- Financial workbook
- Company announcement
- Investor presentation
- Conference call webcast (6 Aug 2020, 13:00 CET)
- Conference call audio link (6 Aug 2020, 13:00 CET)
- London webcast (7 Aug 2020, 13:00 CET)
- London earnings presentation audio link (7 Aug 2020, 13:00 CET)
- Financial workbook
- Company announcement
- Investor presentation
- Conference call
webcast (6 May 2020, 13:00 CET)
- Conference call audio link (6 May 2020, 13:00 CET)
- London webcast (7 May
2020, 13:00 CET)
- London earnings presentation audio link (7 May 2020, 13:00 CET)
- Financial workbook
16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update
30 November: ESG conference call
- Presentation (webcast)
-
ESG presentation (pdf)
- Introduction
- Circular for Zero followed by Q&A
- Defeat Diabetes and Sustainable Workplace followed by Q&A
- Governance structure followed by
Q&A
9 October: Novo Nordisk raises sales and operating profit outlook
for 2020
19 June: R&D investor presentation
26 March: Annual General Meeting
- Conference call webcast (5 February, 13:00 CET)
- London webcast (6 February, 14:15 CET)
- Conference call webcast (1 November, 13:00 CEST)
- London webcast (4 November, 14:15 CEST)
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Investors
Share price
{{priceData.date}} {{priceData.time}}
